Dialysis is performed when kidneys are not functioning properly as required. This procedure helps to remove the waste products and excess fluid from the blood. Patients need dialysis at end-stage kidney failure where the individual has lost 80–90% of kidney function with glomerular filtration rate (GFR <15). Dialysis is the most preferred treatment for many patients and can be done in a hospital, dialysis unit, or at home. There are two type of dialysis – hemodialysis and peritoneal dialysis. Most renal patients undertake hemodialysis (HD) in dialysis centers of clinics and treated during the day or overnight. Peritoneal dialysis is a home-based technique which is used by only 15–18% of the patients.
The market has grown significantly over the last two decades and is fueled with advanced techniques for better diagnosis and product innovation. There are many developed and developing regions where there is a dearth of disease diagnosis. However, the volumes per capita are now picking up in most of the developed countries resulting in unprecedented demand and opportunities for the suppliers.
The rising power of private and public dialysis services and growth in dialysis market with acquisitions and new product launches are attracting many investors. According to our research estimates there are >211 million dialyzers and approximately 73,500 dialysis machines sold globally. The market is growing fast with more than two million patients across the globe who are already in some form of dialysis.
Factors such as rising prevalence of end-stage renal disease (ESRD), growing incidence of diabetes and hypertension, increase geriatric population, and rising drug and healthcare specific expenditures per capita are driving the market. The demand for dialysis is expected to grow with increase in aging population. Obesity, diabetes and hypertension itself constitutes to over 60% of ESRD cases. There are reimbursement programs for dialysis around the globe sponsored by the government. For example, the Medicare programs insures over 80% of the patients with ESRD in the US. This program under the Centers for Medicare and Medicaid Services (CMS) emphasize on reducing outpatient dialysis costs by helping both the service providers and patients with various consolidation programs.
According to Infoholic Research, the “Global Dialysis Market” is expected to grow at a CAGR between 5.5%** and 6.2%** during the forecast period 2019–2025. This report provides detailed study and revenue opportunity of dialysis market across various segments such as dialysis types, equipment’s, consumables, and services. It also provides market information across various regions including North America, Europe, Asia Pacific, and Rest of the World.
The study offers a comprehensive analysis of the “Global Dialysis Market”, providing key insights of the industry. This report aims to cover an in-depth insight, revenue, and competitive analysis regarding the global dialysis market and the various drivers, restraints, and opportunities in the market during the forecast period. Also, the report aims to provide an opportunity for players to understand the current market scenarios, government initiatives, and technologies related to the market. In addition, it helps the venture capitalists in understanding the companies better and take informed decisions.
The market players included in the report are Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., Diaverum Deutschland GmbH., Nikkiso Co. Ltd, DaVita Inc., Nipro Corporation, B. Braun Avitum AG, Rockwell Medical, Inc., Medtronic plc, NxStage Medical, Inc., Asahi Kasei Corporation, and Medivators, Inc.